Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v5-EN
Language French English
Date Updated 2022-12-05 2022-12-05
Drug Identification Number 02464284 02464284
Brand name ADLYXINE ADLYXINE
Common or Proper name ADLYXINE 20 ADLYXINE 20
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients LIXISENATIDE LIXISENATIDE
Strength(s) 20MCG 20MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size Pack of 2 pre-filled pens Pack of 2 pre-filled pens
ATC code A10BJ A10BJ
ATC description
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2022-11-01 2022-11-01
Estimated end date 2022-12-02 2022-12-02
Actual end date 2022-11-17 2022-11-17
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Health Canada comments